The Politics and PR of Cervical Cancer

The Center for Media and Democracy has completed a four part series of articles, The Politics and PR of Cervical Cancer, about the first FDA approved human papillomavirus (HPV) vaccine GARDASIL,...

Poisoning cases raise the need to discuss resources of health care in Finland

"In health care recruitment it is practically impossible to find out comprehensively what kind of misdemeanours or serious crimes a potential member of the nursing staff may have previously committed. The matter was brought to daylight in connection with the murder...

Public Health? Profit? What Drives The HPV Vaccination Campaign?

In November 2006, Merck & Co. Inc. began its high pressure saturation 'One Less' campaign for its genetically engineered drug, GARDASIL, being hailed as a tool to prevent cervical cancer caused by two of...

closeSign in to NowPublic

is reporting from